Pharmacovigilance activities revolve around ensuring drug safety and preventing adverse drug reactions. While post marketing studies form the core of pharmacovigilance, inclusion of safety measures during clinical development and carrying out additional post marketing active surveillance is being utilized by a number of pharma companies.  Risks due to supply and distribution of fake /spurious drugs is also on the rise with many anti -counterfeit solutions being developed. This research service delves into the technology trends in pharmacovigilance and anti-counterfeit technologies and also discusses some of the recent activities and developments from every segment of the industry.